EC
ACIU icon

EcoR1 Capital’s AC Immune ACIU Stock Holding History

EcoR1 Capital’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-485,005
Closed -$1.94M – 81
2022
Q1 		$1.94M Sell
485,005
-264,580
-35% -$1.15M 0.06% 69
2021
Q4 		$3.71M Sell
749,585
-1,666
-0.2% -$9.68K 0.12% 52
2021
Q3 		$5.04M Sell
751,251
-1,896,912
-72% -$13.6M 0.18% 40
2021
Q2 		$21M Sell
2,648,163
-1,000,000
-27% -$6.91M 0.78% 28
2021
Q1 		$27.8M Buy
3,648,163
+1,237,923
+51% +$8.84M 1.23% 21
2020
Q4 		$12.5M Buy
+2,410,240
New +$12.3M 0.67% 25

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

EcoR1 Capital's ACIU Position: Q2 2022 in Review

EcoR1 Capital sold out of AC Immune (ACIU) in Q2 2022, closing a stake of 485,005 shares — an estimated $1.94M sold.

EcoR1 Capital first reported a position in ACIU in Q4 2020 and held it in 6 quarters. The position peaked at $27.8M in Q1 2021. 35 funds tracked by Wall St. Rank hold ACIU as of Q2 2022.

  • EcoR1 Capital reported no remaining AC Immune position as of Q2 2022 after selling out during the quarter.
  • EcoR1 Capital sold 485,005 AC Immune shares in Q2 2022, an estimated $1.94M.
  • EcoR1 Capital first reported a position in AC Immune in Q4 2020 and held it in 6 quarters.
  • EcoR1 Capital's AC Immune position peaked at $27.8M in Q1 2021.
  • 35 funds tracked by Wall St. Rank held AC Immune as of Q2 2022.

Based on EcoR1 Capital's 13F filing for Q2 2022, filed 15 Aug 2022.